One of the many recorded adaptive responses in respiratory chain complex I deficient cells is the over-expression of the small metal binding proteins, metallothioneins (MTs). The antioxidant properties of MTs putatively protect the deficient cells against oxidative damage, thus limiting further damage and impairment of enzymes involved in energy production. Moreover, the role of metallothioneins in supplying metal cofactors to enzymes and transcription factors in order to promote energy metabolism was previously proposed, which could accompany their role as antioxidants. This view is supported by the observations that MT knockout mice tend to become moderately obese, implying a lower energy metabolic rate. Hence, the involvement of metallothioneins in mitochondrial function and disease cannot be ignored. However, this association is still very vague due to the diversity of their functions and the complexity of the mitochondrion. The use of systems biology technology and more specifically metabolomics technology was thus employed to clarify this association by investigating the metabolic differences between wild type and MT knockout mice in unchallenged conditions as well as when mitochondrial function (energy metabolism) was challenged with exercise and/or a high-fat diet. The metabolic differences between these mice were also studied when complex I of the respiratory chain was inhibited with rotenone. The metabolome content of different tissues and bio-fluids were examined in an untargeted fashion using three standardized analytical platforms and the data mined using modern metabolomics and related statistical methods. Clear metabolic differences were found between the wild type and MT knockout mice during unchallenged conditions. These metabolic differences were persisted and were often amplified when mitochondrial metabolism was specifically challenged through exercise, high-fat intake or complex I inhibition. The data pointed to an overall reduced metabolic rate in the MT knockout mice and possible insulin resistance after the interventions which imply (and confirm) the involvement of MTs in promoting energy metabolism in the wild type mice. / Thesis (Ph.D. (Biochemistry))--North-West University, Potchefstroom Campus, 2012

Programmed cell death (PCD) is a highly evolved mechanism of cellular suicide that is aberrantly activated following neural injury. Two fundamental PCD signaling pathways termed the extrinsic (caspase-8-mediated) and intrinsic (caspase-9-mediated) pathways, have been described. While each pathway is initiated by distinct cellular stimuli, both pathways culminate in the activation of downstream executioner caspases. Previous efforts to isolate the in vivo contribution of each pathway have been hindered by the embryonic lethality of casp8 and casp9 null mice. In the present study, I overcame this obstacle to directly assess the contribution of each pathway following two well-characterized forms of acute neural injury; excitotoxic destruction of CA1 pyramidal neurons, and the loss of motor neurons following facial nerve transection. To determine the role of caspase-8, I constructed several lines of mice in which caspase-8 was conditionally ablated within the relevant neuronal populations. The results obtained from these animals definitively demonstrate that caspase-8 is not required by either motor neurons or CA1 pyramidal neurons to undergo PCD following injury. Therefore, these findings have provided the first direct experimental evidence to counter the widely held dogma of caspase-8 as the central effector of death receptor-mediated signaling within neurons. With respect to the intrinsic pathway, several lines of evidence suggest that the apoptosome predominantly regulates the death of motor neurons. I tested this hypothesis by performing facial axotomies in mice containing a point mutation introduced (“knocked in”) into the genomic locus of cytochrome c which abolishes its ability to activate the intrinsic pathway. Homozygous cytochrome c knock-in mice displayed a significant enhancement in motor neuron survival in comparison to control littermates following injury. However, the level of motor neuron protection differed from that previously reported in mice either overexpressing anti-apoptotic or lacking pro-apoptotic members of the Bcl-2 family. Therefore, the results of this study directly demonstrate the influence of the apoptosome on injury-induced neuronal PCD isolated from upstream Bcl-2 family-mediated effects. In addition, my results have provided the first evidence that activation of the apoptosome is required for the release of apoptosis inducing factor (AIF) from the mitochondria of injured motor neurons in vivo.

Zugl.: Würzburg, Univ., Diss., 2008

Würzburg, Universiẗat, Diss., 2008.

Würzburg, Univ., Diss., 2010. / Zsfassung in dt. Sprache.

IRF2BP2 is a corepressor of IRF2, a transcription factor involved in the immune response. IRF2BP2 is also a coactivator of the VGLL4/TEAD4 complex in muscle. Given its functional duality, we asked how IRF2BP2 deletion would affect mouse development and adult muscle regeneration. Most Irf2bp2-/- mice die prior to birth, those that survive develop lymphoma in adulthood. Microarray profiling of Irf2bp2 knockout liver, heart, and skeletal muscle revealed a shared program of upregulated genes involved in inflammation and immunity. The function of IRF2BP2 in adult skeletal muscle recovery from cardiotoxin-induced injury was evaluated. Compared to WT mice, mice with macrophage-specific ablation of IRF2BP2 (Irf2bp2flox/LysMCre) or muscle-specific ablation of Irf2bp2 (Irf2bp2flox/MckCre) mice showed increased inflammation and impaired muscle regeneration. Global deletion of Irf2bp2 in mice results predominantly in embryonic death or lymphoma in adults. Irf2bp2 suppresses genes that mediate inflammation in mouse liver, heart, and in skeletal muscle, where IRF2BP2 promotes regeneration.

Adaptation to environmental fluctuations, through sensing and appropriate physiological responses, is crucial to homeostasis. Neuroepithelial cells (NECs) are putative chemoreceptors resembling mammalian Type I (glomus) cells. They have been shown to respond in vitro to changes in O2, CO2, NH3 and pH. Cytosolic carbonic anhydrase (Ca17a) is thought to be involved in CO2 sensing owing to its presence in NECs. A mutant line of zebrafish (Danio rerio) lacking functional Ca17a was generated using CRISPR/Cas9 technology and used to assess the role of Ca17a in initiating the cardiorespiratory responses to elevated CO2 (hypercapnia). Unfortunately, the homozygous knockout mutants (ca17a-/-) did not survive longer than ~12-14 days post fertilization (dpf), restricting experiments to early developmental stages (4-8 dpf). Changes in ventilation (fV) and cardiac (fH) frequency in response to hypercapnia (1% CO2) in wild type (ca17a+/+), heterozygous (ca17a+/-) and ca17a-/- fish were used to investigate Ca17a-dependent CO2 sensing and downstream signalling. Wild type fish exhibited hyperventilation during hypercapnia as indicated by an increase in fV. In the ca17a-/- fish, the hyperventilatory response was attenuated markedly, but only at 8 dpf. Hypercapnic tachycardia was observed for all genotypes and did not appear to be influenced by the absence of Ca17a. Interestingly, ca17a-/- fish exhibited a significantly reduced resting fH¬. This effect of knockout became more pronounced as the fish aged. Anesthesia did not contribute to the decreased fH in the ca17a-/- fish, nor did changes in cardiac adrenergic or cholinergic tone, which were probed using propranolol (-adrenergic receptor blocker) or atropine (muscarinic receptor blocker). The decrease in resting fH was prevented (“rescued”) when ca17a-/- embryos were injected with ca17a mRNA. Collectively, the results of this thesis support a role for Ca17a in promoting hyperventilation during hypercapnia in larval zebrafish and suggest a previously unrecognized role for Ca17a in determining resting heart rate.

Neuste Studien haben ergeben, dass Asc-1 Knock-out Mäuse aufgrund einer verminderten intrazellulären Glycinkonzentration in synaptischen Boutons im Gehirn, einen Hyperekplexie-ähnlichen Phänotyp entwickeln. Aufgrund nicht vollständig geklärter Ursachen für die Entstehung des Krankheitsbildes der Hyperekplexie beim Menschen, wurde eine Kohorte von 51 Patienten zusammengetragen, um vor dem Hintergrund der Forschungsergebnisse zu Asc-1 im Tiermodell, das kodierende Gen beim Menschen SLC7A10 als mögliches Kandidatengen auf Sequenzalterationen zu untersuchen. Hierfür wurde aus Vollblut der an Hyperekplexie erkrankten Patienten genomische DNA isoliert, um mittels PCR und anschließendem Screening der Sequenzen, Mutationen innerhalb funktionell wichtiger Bereiche des Gens zu eruieren. Neben weiteren Sequenzunterschieden, die meist in Introns gefunden wurden, wurde die codierende Mutation G307R innerhalb von Exon 7 identifiziert, die letztendlich der Grund für eine Versuchsreihe war, um zu hinterfragen, ob dieser Aminosäureaustausch in der Proteinsequenz funktionelle Konsequenzen zur Folge hat. HEK293-Zellen wurden mit dem zuvor hergestellten Klon G307R transfiziert, um über Biotinylierung, immuncytochemische Färbungen und funktionelle Untersuchungen die Aktivität des Transporters zu beurteilen. Hier zeigte sich ein Funktionsverlust von über 95 %, bei uneingeschränkter Oberflächenexpression. ASC-1 bestätigt sich damit als neue Ursache in der Ausprägung von Hyperekplexie. Ferner können Zusammenhänge mit geistiger Retardierung und eingeschränkter neuronaler Plastizität bestehen. / Recent studies have shown that Asc-1 knock-out mice leads to reduced intracellular glycine concentration in synaptic boutons in the brain followed by a development of a hyperekplexia-like phenotype. In humans, the underlying cause for hyperekplexia is not complexly understood. Based on findings in the Asc-1 knockout mouse model, a patient cohort of 51 patients was used to identify possible sequence alterations in the corresponding Gen SLC7A10 as a novel candidate gene for human hyperekplexia. For this purpose, genomic DNA was extracted from blood samples of patients suffering from hyperekplexia to identify mutations within functionally important areas of the gene by means of PCR and subsequent analyses of the determined sequences. Besides other sequence alterations mainly in introns, the coding mutation G307R within exon 7 was identified and used to investigate functional consequences of this amino acid exchange in an experimental series. The clone ACS-1 G307R was transfected into HEK293 cells to assess the activity of the transporter via biotinylation, immunocytochemical stainings, and functional uptake assays. Our results showed an almost loss of function with more than 95 % reduction in the transport activity although surface expression was unaffected. In conclusion, the ASC-1 mutation was confirmed as a novel cause for human hyperekplexia. In addition, mental retardation and restricted neuronal plasticity might play a role during disease manifestation.

Coffin-Lowry syndrome is a rare syndromic form of X-linked mental retardation caused by heterogeneous loss-of-function mutations in the gene RPS6KA3 that encodes the RSK2 protein. Clinical features are delayed motor development, small height, progressive skeletal malformations and mental retardation. Rsk2 deficiency affects behavioral, cellular and molecular functions. To characterize and investigate how this deficiency affects these functions, we made a series of experiments using Rsk2-deficient mice as the animal model for Coffin-Lowry syndrome. We applied a battery of behavioral tests and included the use of the IntelliCage for the first time as a behavioral paradigm to study anxiety-like behavior and depression-like behavior in Rsk2-deficient mice. Results from the conventional behavioral tests and from the IntelliCage indicate that Rsk2-deficient mice may have an anti-anxiety and anti-depressive phenotype. We evaluated in Rsk2 deficient mice the relative gene expression of a set of genes coding for proteins related to RSK2 which are involved in fear memory, synaptic plasticity, neurogenesis, learning, emotional behavior and stress. We found gene expression alterations in the prefrontal cortex and striatum. These results suggest that RSK2 may be involved in the expression of the genes. RSK2 is known to be related to monoamine neurotransmitter function. We measured the levels of dopamine, serotonin and noradrenaline/norepinephrine and their metabolites in different brain regions of Rsk2-deficient mice. We found differences in the dopaminergic and noradrenergic systems suggesting an increased or decreased activity of these neurotransmission systems as a result of Rsk2 deficiency. Adult neurogenesis is a form of neuronal plasticity and a multi-step process of cell development. We explored if this form of neuronal plasticity was affected by Rsk2-deficiency. Our results indicate that adult hippocampal neurogenesis is not influenced by lifelong Rsk2 deficiency. It would be worth to analyze in the future other aspects of neuroplasticity. We have confirmed, that behavioral characteristics of Rsk2-deficient mice make them an interesting model to study the Coffin-Lowry syndrome by extending the behavioral characterization on the emotional level. Furthermore, we have extended the characterization of the model on a molecular level, opening new opportunities to study and understand the pathophysiological basis of the Coffin-Lowry syndrome. / Das Coffin-Lowry Syndrom ist eine seltene syndromale Form X-gebunden vererbter geistiger Behinderung, verursacht durch heterogene loss of function Mutationen im RPS6KA3-Gen, welches für das RSK2-Protein kodiert. Klinische Charakteristika sind eine verzögerte motorische Entwicklung, eine geringe Körpergröße, fortschreitende Skelett- Malformationen und geistige Behinderung. Die Rsk2-Mutation hat einen Einfluss auf das Verhalten, auf zelluläre und molekulare Funktionen. Um zu charakterisieren und zu untersuchen, wie diese Defizienz diese Funktionen beeinflusst, führten wir eine Reihe von Experimenten durch und verwendeten Rsk2-defiziente Mäuse als Tiermodell für das Coffin-Lowry Syndrom. Wir wandten eine Reihe von Verhaltens-Tests an, einschließlich erstmals den IntelliCage als ein Verhaltensparadigma, um Angst-ähnliches und Depressions-ähnliches Verhalten in Rsk2-defizienten Mäusen zu untersuchen. Ergebnisse konventioneller Verhaltenstests und aus dem IntelliCage sprechen dafür, dass Rsk2-defiziente Mäuse einen „anti-ängstlichen“ und „anti-depressiven“ Phänotyp haben. Wir haben bei Rsk2-defizienten Mäusen die Expression einer Reihe von Genen untersucht, die für Proteine kodieren, die mit RSK2 in Zusammenhang stehen und darüber hinaus eine Bedeutung für das Angst-Gedächtnis, synaptische Plastizität, Neurogenese, Lernen, emotionales Verhalten und Stress haben. Im präfrontalen Kortex und Striatum konnten wir Genexpressionsunterschiede zwischen Rsk2-Wildtyp- und Knockout-Mäusen detektieren. Diese Ergebnisse sprechen dafür, dass RSK2 eine Rolle bei der Expression dieser Gene spielt. Es ist bekannt, dass RSK2 eine Rolle für die monoaminerge Neurotransmitter-Funktion spielt. Deshalb haben wir die Konzentration von Dopamin, Serotonin und Noradrenalin/Norepinephrin und ihrer Metaboliten in verschiedenen Gehirnregionen von Rsk2-defizienten Mäuse untersucht. Wir haben Unterschiede im dopaminergen und noradrenergen System gefunden, was auf eine gesteigerte oder verminderte Aktivität dieser Neurotransmittersysteme als Folge der Rsk2-Defizienz hinweist. Adulte Neurogenese ist eine Form neuronaler Plastizität und ein mehr-stufiger Prozess zellulärer Entwicklung. Unsere Untersuchungen der adulten Neurogenese im Hippocampus zeigten, dass sie nicht durch eine lebenslange Rsk2-Defizienz beeinflusst wird. In Zukunft wäre es jedoch sinnvoll, andere Aspekte der Neuroplastizität zu analysieren. Durch unsere Verhaltensstudien wurde die Charakterisierung der Rsk2-defizienten Mäuse vor allem im emotionalen Bereich stark erweitert, wodurch wir bestätigen konnten, dass diese Mauslinie ein interessantes Modell zur Untersuchung des Coffein-Lowry Syndroms ist. Darüber hinaus haben wir die Charakterisierung des Modells auf der molekularen Ebene erweitert und damit neue Möglichkeiten eröffnet, die pathophysiologische Grundlage des Coffin-Lowry Syndroms zu studieren.

Plants as sessile organisms are susceptible to many environmental stresses such as drought, and salinity. They have therefore evolved mechanisms to acclimate and tolerate environmental stresses. Knowledge of the molecular aspects of abiotic stress gleaned from extensive studies in Arabidopsis has provided much information on the complex processes underlying plant response to abiotic stresses. Nevertheless, there is a need for integration of the knowledge gained and a systematic molecular genetic dissection of the complex responses to abiotic stress. In this study in Arabidopsis, comparative expression profiling analysis of progressive (pDr) and moderate (mDr) drought treatments revealed common drought responses, as well as treatment specific signatures responses to drought stress. Under prolonged moderate drought plants develop different mechanisms for acclimation: induction of cell wall loosening at early stage, and a change in hormonal balance (ABA: JA) at late stage of moderate drought. Taking a reverse genetics approach, a MYB transcription factor (MYB109) has been identified as a regulator of growth under drought and salt stress. Global expression profiling showed possible mechanisms of how MYB109 modulates growth under drought conditions: as a regulator of RNA processing and splicing and as a negative regulator of jasmonic acid biosynthesis and signaling. A forward genetics screen for drought and salt tolerance of transposon activation tag (ATag) lines led to the discovery of novel genes, which shed light on unexplored areas of abiotic stress biology. Utilizing this strategy, a potential role for cell wall modification and MATE transporters in response to drought and salt stress has been discovered, which needs further analysis to integrate this information on the role of these biological processes in plant stress biology. / Ph. D.